Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Targeting Methods for Transcranial Magnetic Stimulation Treatment of Depression
Sponsor: Stanford University
Summary
We aim to learn whether use of a mixed reality device for transcranial magnetic stimulation (TMS) targeting can improve treatment outcomes compared to targeting through scalp measurements or a commercial neuronavigation system. Prior studies indicate that neuronavigation can lead to improved treatment outcomes compared to scalp measurements, but neuronavigation adaption has been lacking due to the increased burden of the neuronavigation setup on the TMS operator. We will assess whether use of a mixed reality device can decrease that burden and speed up the neuronavigation process and is feasible to be used in a clinical setting.
Official title: Evaluating the Effectiveness of Different Targeting Approaches for Transcranial Magnetic Stimulation Treatment of Depression
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-01-01
Completion Date
2026-12-31
Last Updated
2021-05-07
Healthy Volunteers
No
Conditions
Interventions
Transcranial Magnetic Simulation
Brain stimulation treatment will be performed using FDA-cleared TMS coils according to their intended use of treatment of medication resistant depression by targeting the dorsolateral prefrontal cortex.
Mixed reality neuronavigation
Targeting of the dorsolateral prefrontal cortex will be performed with the help of a mixed reality neuronavigation system.
Locations (1)
Stanford University
Stanford, California, United States